Glenmark Life Sciences Limited
Share Price Target & Analysis
NSE:GLS
VWAP
Open
Close
High
Low
52 Week High
-8.00 (-0.59%)
GLS
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: GLS Share Price Financial Analysis & Valuation
Glenmark Life Sciences Limited (GLS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Small Cap company with Market Capitalization of Rs 6925.9 (in Cr). Total number of free float shares are 0 (in Lacs).
Glenmark Life Sciences Limited is listed on NSE with Exchange ID - INE03Q201024 and trading code is NSE:GLS with short name Alivus Life.
In the past 1 year, Glenmark Life Sciences Limited has declared an equity dividend of Rs 21 per share. At the current share price of GLS at Rs 1350.20, this results in a dividend yield of 1.56 %.
As per the Fundamental Analysis of NSE:GLS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLS underlying value and future prospects. All of this data is available in GLS financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:GLS, it is clearly understood that GLS is Economical performer in terms of earnings and profit margins with an EPS of 49.12. NSE:GLS book value per share as of today is 284.45. The current price to book ratio for GLS as of Sep 10, 2026 is 4.75.
Valuation of the Stock: The current valuation of GLS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLS whether to BUY this stock at current valuation. The delivery percentage of GLS is 54.22% is very crucial parameter which shows that 54.22% investors are anticipating that the price of GLS share should go up with VWAP at 1350.75.
Now, the main question is whether to BUY or SELL, NSE:GLS at current valuation.
As per latest Analysis No. #1925:-
⇑ STRONG BUY GLS if All Greens
⇗ BUY GLS (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD GLS (With Stop Loss) if only 1 Green
⇘ SELL GLS if NO Green Indicator
NSE: GLS Share Price Today (Sep 10, 2026)
(Glenmark Life Sciences Limited Daily Analysis on the basis of GLS Intraday Graph & Trend)
Glenmark Life Sciences Limited share price moved Down by -0.59% from its previous close of Rs 1358.2. GLS stock last traded price is 1350.20. GLS share price trend is Down with a total of 51812 stocks traded till now. It has touched an intraday high of Rs 1375.9 and an intraday low of Rs 1338.2. The GLS trading at 1350.20, Down by Rs. -8.00, or -0.59 percent which suggests that most of the Traders are anticipating that the price of GLS share should go Down.
NSE: GLS Share Price Tomorrow Prediction
(Glenmark Life Sciences Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLS)
Glenmark Life Sciences Limited share price moved Down by -0.59%. GLS share price short term trend is Down. It suggests that GLS Share Price for Tomorrow remains the same with VWAP at 1350.75 will be treated as stop loss for intraday traders. Glenmark Life Sciences Limited Long term investors can follow the GLS long term trend as mentiond in future forecast table.
NSE Code |
NSE: GLS |
GLS Share Price Today |
1350.20 |
GLS Share Price Target Prediction for 2026 ^ |
1075.5 - 1425 |
GLS Share Price Target Prediction for 2027*^ |
1425 - 1518.1 |
GLS Share Price Target Prediction for 2028*^ |
1518.1 - 1624.4 |
GLS Share Price Target Prediction for 2029*^ |
1706 |
GLS Share Price Target Prediction for 2030*^ |
1754 |
GLS Share Price Target Prediction for 2035*^ |
1912 |
| GLS Current Book Value |
283 |
*Glenmark Life Sciences Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^GLS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
GLS Technical Analysis (In Process... .. .)
Please wait for a while and refresh the page to check again.
Most popular Questions & Answers about GLS (/ FAQ GLS)
Glenmark Life Sciences Limited stock last traded price is 1350.20. GLS share price moved Down by -0.59% from its previous close of Rs 1358.2.
Glenmark Life Sciences Limited share price trend is Down with a total of 51812 stocks traded till now. It has touched an intraday high of Rs 1432.18 and an intraday low of Rs 1338.2. The GLS trading at 1350.20, Down by Rs. -8.00, or -0.59 percent which suggests that most of the Traders are anticipating that the price of GLS share should go Down and the Stop Loss will be around 1350.75.
The market cap of Glenmark Life Sciences Limited is ₹6925.9 (in Cr) as of Sep 09, 2026.
The current price to earning ratio for Glenmark Life Sciences Limited as of Sep 09, 2026 is 52.86.
The current price to book ratio for Glenmark Life Sciences Limited as of Sep 09, 2026 is 4.75.
The highest price of Glenmark Life Sciences Limited stock is ₹1418 in the last 52-week.
The lowest price of Glenmark Life Sciences Limited stock is ₹819 in the last 52-week.
Glenmark Life Sciences Limited share trading at ₹1350.20, Down by Rs. -8.00, or -0.59 percent which suggests that most of the traders are anticipating that the price of GLS share should go Down.
In 2026, Stock price target for Glenmark Life Sciences Limited (GLS) will be around ₹1075.5 on downside and ₹1425 on upside. Glenmark Life Sciences Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Glenmark Life Sciences Limited (GLS) will be around ₹1425 on downside and ₹1518.1 on upside. Glenmark Life Sciences Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Glenmark Life Sciences Limited (GLS) will be around ₹1518.1 on downside and ₹1624.4 on upside. Glenmark Life Sciences Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Glenmark Life Sciences Limited (GLS) will be around ₹1754 Glenmark Life Sciences Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLS.
The price of Glenmark Life Sciences Limited (GLS) shares moved by -0.59%. The short-term trend for GLS share price is Down. It implies that the share price of GLS will stay the same tomorrow and that intraday traders should treat VWAP at 1350.75 as a stop loss. Investors with a long-term outlook can track GLS long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of GLS stock is 588.9. Compared to the current market price of 1350.20 INR, the GLS stock is Overvalued by 56.4%.
As per the fundamental analysis of Glenmark Life Sciences Limited (GLS), it is of Economical quality in terms of earnings and profit margins with an EPS of 49.12. Glenmark Life Sciences Limited book value per share as of today is 284.45. The current price to book ratio for GLS as of Sep 10, 2026 is 4.75.
NSE:GLS News & Other Useful Information about GLS Share Price
Peer Comparison of NSE: GLS
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1117.80 | 40.96 | 238.63 |
| GLAND | 2946.90 | 89.58 | 677.38 |
| CADILAHC | 1117.80 | 40.96 | 238.63 |
| MADHAVBAUG | 158.95 | 10.03 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1356.60 | 29.16 | 234.07 |
| PGHL | 5425.50 | 211.15 | 373.93 |
| SYMBIOTEC | 1138.95 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 917.45 | 29.51 | 151.81 |
| SIGACHI | 37.56 | -1.7 | 12.62 |
| SAKAR | 1117.30 | 24.29 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 23.00 | 2.55 | 18.08 |
| JSLL | 518.30 | 21.7 | 42.89 |
| JFLLIFE | 10.65 | 2.27 | 12.12 |
| MANKIND | 2238.40 | 59.75 | 410.5 |
| SOTAC | 90.05 | 6.71 | 52.33 |
| REMUS | 893.05 | 23.29 | 276.4 |
| VILINBIO | 58.95 | 1.57 | 18.6 |
| SAROJA | 39.80 | 4.29 | 43 |
| VALIANTLAB | 124.80 | 1.44 | 60.62 |
| BLUEJET | 575.30 | 15.67 | 82.91 |
| ACCENTMIC | 706.90 | 20.63 | 114.84 |
| ZENITHDRUG | 46.35 | 5.83 | 43.69 |
| INNOVACAP | 1167.40 | 21.16 | 160.54 |
| ENTERO | 1792.90 | 8.88 | 387.5 |
| EMCURE | 1962.80 | 51.69 | 206.16 |
| MEDIORG | 25.20 | -1.83 | 21.18 |
| AKUMS | 749.65 | 10.26 | 157.14 |